Urs Wagner

4.2k total citations · 1 hit paper
21 papers, 2.7k citations indexed

About

Urs Wagner is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Urs Wagner has authored 21 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Surgery and 9 papers in Molecular Biology. Recurrent topics in Urs Wagner's work include Bladder and Urothelial Cancer Treatments (8 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer-related Molecular Pathways (3 papers). Urs Wagner is often cited by papers focused on Bladder and Urothelial Cancer Treatments (8 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer-related Molecular Pathways (3 papers). Urs Wagner collaborates with scholars based in Switzerland, United States and Finland. Urs Wagner's co-authors include Guido Sauter, Michael J. Mihatsch, Thomas C. Gasser, Holger Moch, Lukas Bubendorf, Niels Willi, Holger Moch, Peter Schraml, Olli Kallioniemi and Jan Richter and has published in prestigious journals such as Nature Genetics, PLoS ONE and Oncogene.

In The Last Decade

Urs Wagner

21 papers receiving 2.6k citations

Hit Papers

Metastatic patterns of prostate cancer: An autopsy study ... 2000 2026 2008 2017 2000 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Urs Wagner Switzerland 18 1.2k 1.1k 1.0k 684 556 21 2.7k
Aasmund Berner Norway 33 960 0.8× 873 0.8× 1.2k 1.2× 489 0.7× 582 1.0× 99 3.3k
Hee Eun Lee South Korea 29 1.3k 1.1× 707 0.6× 1.0k 1.0× 418 0.6× 680 1.2× 86 2.7k
Yingyong Hou China 28 1.1k 0.9× 1.0k 0.9× 1.1k 1.0× 787 1.2× 602 1.1× 233 2.9k
Waldemar Wilczak Germany 30 842 0.7× 826 0.8× 1.1k 1.1× 344 0.5× 599 1.1× 93 2.3k
Ole J. Halvorsen Norway 26 738 0.6× 1.2k 1.1× 1.6k 1.6× 263 0.4× 748 1.3× 79 3.0k
S. Aaltomaa Finland 31 1.3k 1.1× 754 0.7× 1.2k 1.2× 385 0.6× 803 1.4× 93 3.0k
Yoon‐La Choi South Korea 35 1.6k 1.4× 930 0.9× 1.4k 1.4× 372 0.5× 1.1k 2.0× 125 3.7k
Jochen Meyer Germany 22 759 0.6× 1.3k 1.2× 1.7k 1.7× 513 0.8× 1.4k 2.5× 43 4.6k
Neda Kalhor United States 32 1.9k 1.6× 1.9k 1.8× 1000 1.0× 642 0.9× 807 1.5× 118 4.1k
Michael T. Schweizer United States 33 1.1k 0.9× 2.2k 2.0× 929 0.9× 321 0.5× 746 1.3× 144 3.1k

Countries citing papers authored by Urs Wagner

Since Specialization
Citations

This map shows the geographic impact of Urs Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Urs Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Urs Wagner more than expected).

Fields of papers citing papers by Urs Wagner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Urs Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Urs Wagner. The network helps show where Urs Wagner may publish in the future.

Co-authorship network of co-authors of Urs Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of Urs Wagner. A scholar is included among the top collaborators of Urs Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Urs Wagner. Urs Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Varga, Zsuzsanna, Joachim Diebold, Corina Dommann‐Scherrer, et al.. (2012). How Reliable Is Ki-67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists. PLoS ONE. 7(5). e37379–e37379. 169 indexed citations
2.
3.
Hoch, Matthias, Alex N. Eberlé, Urs Wagner, et al.. (2007). Expression and Localization of Melanocortin‐1 Receptor in Human Adipose Tissues of Severely Obese Patients. Obesity. 15(1). 40–49. 37 indexed citations
4.
Tapia, Coya, Spasenija Savic, Urs Wagner, et al.. (2007). HER2gene status in primary breast cancers and matched distant metastases. Breast Cancer Research. 9(3). R31–R31. 95 indexed citations
5.
Weeraratna, Ashani T., Dorothea Becker, Paul H. Duray, et al.. (2004). Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome. Oncogene. 23(12). 2264–2274. 57 indexed citations
6.
Simon, Ronald, Ramin Atefy, Urs Wagner, et al.. (2003). HER‐2 and TOP2A coamplification in urinary bladder cancer. International Journal of Cancer. 107(5). 764–772. 78 indexed citations
7.
Skotheim, Rolf I., Vera M. Abeler, Jahn M. Nesland, et al.. (2003). Candidate Genes for Testicular Cancer Evaluated by In Situ Protein Expression Analyses on Tissue Microarrays. Neoplasia. 5(5). 397–404. 43 indexed citations
8.
Andersen, Claus L., Outi Monni, Urs Wagner, et al.. (2002). High-Throughput Copy Number Analysis of 17q23 in 3520 Tissue Specimens by Fluorescence in Situ Hybridization to Tissue Microarrays. American Journal Of Pathology. 161(1). 73–79. 60 indexed citations
9.
Simon, Ronald, Kirsten Struckmann, Peter Schraml, et al.. (2002). Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer. Oncogene. 21(16). 2476–2483. 115 indexed citations
10.
Richter, Jan, Urs Wagner, Ester Rozenblum, et al.. (2001). Molecular cytogenetic alterations associated with rapid tumor cell proliferation in advanced urinary bladder cancer. International Journal of Oncology. 18(6). 1239–44. 17 indexed citations
11.
Mousses, Spyro, Urs Wagner, Yidong Chen, et al.. (2001). Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling. Oncogene. 20(46). 6718–6723. 97 indexed citations
12.
Mousses, Spyro, Lukas Bubendorf, Juha Kononen, et al.. (2001). Gene expression changes during hormonal therapy for prostate cancer reveal candidate diagnostic and drug targets. Nature Genetics. 27(S4). 75–75. 1 indexed citations
13.
Bubendorf, Lukas, Urs Wagner, Guido Sauter, et al.. (2000). Metastatic patterns of prostate cancer: An autopsy study of 1,589 patients. Human Pathology. 31(5). 578–583. 1350 indexed citations breakdown →
14.
Wagner, Urs, U Schmid, Daniel Ackermann, et al.. (1999). Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer. The Journal of Pathology. 188(1). 44–50. 43 indexed citations
15.
Wagner, Urs, Holger Moch, Juha Kononen, et al.. (1999). EVALUATION OF PROGNOSTIC MARKERS IN URINARY BLADDER CANCER USING TUMOR TISSUE ARRAYS. The Journal of Urology. 174–174. 2 indexed citations
16.
Wagner, Urs, et al.. (1999). Patterns of Metastasis in Muscle-Invasive Bladder Cancer (pT2–4): An Autopsy Study on 367 Patients. Urologia Internationalis. 62(2). 69–75. 112 indexed citations
17.
Zhao, Jianming, Jan Richter, Urs Wagner, et al.. (1999). Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa).. PubMed. 59(18). 4658–61. 93 indexed citations
18.
Richter, Jan, Urs Wagner, Peter Schraml, et al.. (1998). Patterns of Chromosomal Imbalances in Advanced Urinary Bladder Cancer Detected by Comparative Genomic Hybridization. American Journal Of Pathology. 153(5). 1615–1621. 115 indexed citations
19.
Sauter, Guido, Georg E. Feichter, J. Torhorst, et al.. (1996). Fluorescence <i>in Situ</i> Hybridization for Detecting ErbB-2 Amplification in Breast Tumor Fine Needle Aspiration Biopsies. Acta Cytologica. 40(2). 164–173. 50 indexed citations
20.
Sauter, Guido, Holger Moch, Urs Wagner, et al.. (1995). Y chromosome loss detected by FISH in bladder cancer. Cancer Genetics and Cytogenetics. 82(2). 163–169. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026